Exeter announces new £3.4 million global funding for solutions to antifungal drug resistance

  06 May 2024

Researchers working on antifungal resistance solutions are being encouraged to apply to a £3.4 million fund led by the University of Exeter, UK government funding. The new FAILSAFE (Fungal AMR Innovations for LMICS: Solutions and Access For Everyone) fund is being launched by the University of Exeter’s MRC Centre for Medical Mycology in partnership with the UK Department of Health and Social Care’s Global AMR Innovation Fund (GAMRIF). The fund aims to address the urgent need for solutions to life-threatening fungal diseases, which take as many lives annually as TB or malaria. The increasing frequency of antifungal drug resistance among fungi in the natural environment and in patients undergoing hospital treatment means even fewer drugs are effective. The FAILSAFE project will distribute its funds to innovative projects that deliver products or solutions for AFR, led by researchers from across the globe.

Further reading: EurekAlert
Author(s): University of Exeter
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed